14.11.2014 Views

Ionix Pharmaceuticals - Molecular Devices

Ionix Pharmaceuticals - Molecular Devices

Ionix Pharmaceuticals - Molecular Devices

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Using the FLEXstation to<br />

investigate voltage-gated<br />

calcium and sodium<br />

channels<br />

Stuart Ward<br />

<strong>Ionix</strong> <strong>Pharmaceuticals</strong><br />

May 2002<br />

1


Outline of Talk<br />

<strong>Ionix</strong> Profile<br />

Role of FLEXstation in <strong>Molecular</strong><br />

Pharmacology Group<br />

Assays investigating voltage-gated ion<br />

channels:<br />

Calcium<br />

Sodium<br />

2


<strong>Ionix</strong> Profile<br />

Founded July 2001, Cambridge UK<br />

Discovery of novel analgesic drugs<br />

Proprietary drug targets including ion<br />

channels<br />

Drug development to Phase II<br />

3


Role of FLEXstation<br />

To play a key role in assay development<br />

To be used in medium throughput drug<br />

screening<br />

Initially used in the development of<br />

assays to investigate voltage-gated<br />

calcium and sodium channels expressed<br />

in neuroblastoma cell lines<br />

4


Voltage-gated Calcium Channels<br />

IMR32 cells have been used to<br />

investigate calcium channels<br />

Human neuroblastoma<br />

Express L-type and N-type channels<br />

(differentiate for N-type)<br />

Used in low throughput assays<br />

5


Aim<br />

To develop a medium throughput<br />

fluorescence-based assay using IMR32<br />

cells in 96-well plate format<br />

6


IMR32 Cell Culture Conditions<br />

Cells grown in EMEM supplemented with<br />

2mM Glutamine+1%NEAA+10%FBS<br />

Cells were split 1:2/1:3 every 2-3 days<br />

or had the media changed<br />

Differentiate with 1mM dibutyryl cAMP<br />

and 2.5µM bromodeoxyuridine for 8-10<br />

days<br />

7


Adherent vs Suspension Assay<br />

Cells used in suspension<br />

IMR32 cells adhere to surfaces weakly<br />

Changing media every 2-3 days causes<br />

large loss of cells when grown in 96 well<br />

plates<br />

Cells grown in tissue culture flasks<br />

(under differentiating conditions, if<br />

necessary) and then loaded with<br />

fluorescent indicator and assayed in<br />

suspension<br />

8


Fura-2<br />

Fluorescent Indicator<br />

340/380 ratio<br />

Disadvantage: It cannot easily be used with<br />

a FLIPR<br />

Fluo-4 was used in screening assay<br />

Can be used in FLIPR and hence in highthroughput<br />

assays<br />

Data obtained do not require ratio<br />

calculations. Therefore are easily<br />

manipulated<br />

9


Assay Protocol<br />

Detach cells and resuspended in assay<br />

buffer<br />

Incubate with 2.3µM Fluo-4 or 5µM Fura-2,<br />

50mM probenecid for 30min with rotation<br />

Centrifuge and resuspend in assay buffer<br />

Dispense 2x10 5 cells/well<br />

Assay using the FLEXstation. KCl added by<br />

fluidics system to stimulate calcium<br />

channel opening<br />

10


KCl-Induced Calcium Changes In<br />

IMR-32 Cells<br />

2.00<br />

KCl (mM)<br />

1.5<br />

Ratio 340/380<br />

1.75<br />

1.50<br />

50<br />

30<br />

10<br />

5<br />

0<br />

1.25<br />

0 10 20 30<br />

Response<br />

(Area Under Curve)<br />

1.0<br />

0.5<br />

0.0<br />

-0.5<br />

1 10 100<br />

Time (s)<br />

KCl (mM)<br />

11


Calcium Channel Assays<br />

N-Type Assay:<br />

8-10 day differentiated IMR32 cells<br />

Assay run in the presence of nitrendipine or<br />

nicardipine to block L-type component<br />

L-Type Assay (two strategies):<br />

8-10 day differentiated IMR32 cells<br />

Need to block N-type component with<br />

-conotoxin GVIA (expensive option)<br />

Undifferentiated IMR32 cells (preferred<br />

option)<br />

No N-type component<br />

12


1M Nicardipine<br />

+1M -CnTxGVIA<br />

13<br />

Pharmacology of Calcium<br />

Channels in Differentiated<br />

IMR-32 Cells<br />

10.0<br />

7.5<br />

5.0<br />

2.5<br />

Control<br />

1µM Nicardipine<br />

Response<br />

(Area Under Curve)<br />

2.00<br />

1.75<br />

1.50<br />

1.25<br />

1.00<br />

Control<br />

50mM KCl<br />

1µM Nicardipine<br />

1µM Nicardipine<br />

+1µM -CnTxGVIA<br />

0.0<br />

0 10 20 30 40<br />

Time (s)<br />

Ratio 340/380


Measuring Fluo-4 Calcium Responses<br />

150000<br />

FLEXstation Output<br />

Response (RFU)<br />

100000<br />

50000<br />

0<br />

KCl<br />

Basal set to zero<br />

Max-Min<br />

Response<br />

14<br />

-50000<br />

0 10 20 30 40 50<br />

Time (sec)


Increasing CaCl 2 Concentration<br />

in Stimulation Buffer<br />

Increasing CaCl 2 in<br />

assay buffer:<br />

Increasing CaCl 2 in KCl<br />

stimulation solution:<br />

100000<br />

100000<br />

Peak Response<br />

75000<br />

50000<br />

25000<br />

Peak Response<br />

75000<br />

50000<br />

25000<br />

0<br />

1.25 2.50 5.00 10.00<br />

CaCl 2 Concentration (mM)<br />

0<br />

1.25 2.50 5.00 10.00 20.00<br />

CaCl 2 Concentration (mM)<br />

+buffer<br />

+50mM KCl<br />

+buffer<br />

+50mM KCl<br />

15


Assay Validation<br />

Calcium channel blockers were used to validate<br />

the assay<br />

Nimodipine<br />

-Conotoxin-GVIA<br />

Response (% Max)<br />

100<br />

75<br />

50<br />

25<br />

0<br />

Response (% Max)<br />

100<br />

75<br />

50<br />

25<br />

0<br />

0.0001 0.001 0.01 0.1 1 10 100 1000<br />

Nimodipine concentration (M)<br />

N-Type IC 50 = 5.3 M<br />

L-Type IC 50 = 13 nM<br />

1 10 100<br />

-Conotoxin-GVIA concentration<br />

(nM)<br />

N-type IC 50 = 5.5 nM<br />

L-type No Block<br />

16


Calcium Channel Screen<br />

50,000 compound library screened<br />

40 plates/day on FLEXstation<br />

Data analyzed with SOFTmax Pro<br />

17


Assay Plate Layout<br />

Positive<br />

Control<br />

Negative<br />

Control #1<br />

Negative<br />

Control #2<br />

18<br />

80 Test Compounds<br />

(single concentration)


19<br />

SOFTmax PRO Data Analysis


20<br />

SOFTmax PRO Data Analysis


Summary<br />

Developed assay to analyze voltagegated<br />

calcium channels on FLEXstation<br />

Assay now in routine use in screening<br />

laboratory<br />

21


Voltage-gated Sodium Channels<br />

Use of <strong>Molecular</strong> <strong>Devices</strong> Membrane<br />

Potential Assay Kit<br />

Panel of cell lines investigated<br />

Kelly<br />

BE(2)C<br />

SH-SY-5Y<br />

ND7/23<br />

Human neuroblastoma<br />

Human neuroblastoma<br />

Human neuroblastoma<br />

Hybrid of mouse neuroblastoma and rat DRG<br />

22


Experimental Conditions<br />

Neuroblastoma cell lines grown in<br />

96-well plates<br />

Dye loading according to <strong>Molecular</strong><br />

<strong>Devices</strong> protocol<br />

Except that all cells were initially loaded for<br />

60min at 37ºC<br />

Veratridine used to stimulate sodium<br />

channel response<br />

Added by FLEXstation fluidics system<br />

23


Measuring Sodium Channel<br />

Responses<br />

FLEXstation Output<br />

80000<br />

Response (RFU)<br />

60000<br />

40000<br />

Veratridine<br />

Max-Min<br />

Response<br />

20000<br />

0 25 50 75 100<br />

Time (sec)<br />

24


Assay Validation<br />

Responses measured in BE(2)C cells<br />

Veratridine<br />

Tetrodotoxin<br />

(100M Veratridine)<br />

100000<br />

100000<br />

Response (RFU)<br />

75000<br />

50000<br />

25000<br />

Response (RFU)<br />

75000<br />

50000<br />

25000<br />

0<br />

1 10 100 1000<br />

0<br />

0.01 0.1 1 10 100 1000 10000<br />

Veratridine concentration (M)<br />

EC 50 = 13 M<br />

Tetrodotoxin concentration (nM)<br />

IC 50 = 6 nM<br />

25


Assay Validation<br />

Responses measured in SH-SY-5Y cells<br />

Veratridine<br />

Tetrodotoxin<br />

(100M Veratridine)<br />

Response (RFU)<br />

100000<br />

75000<br />

50000<br />

25000<br />

Response (RFU)<br />

100000<br />

75000<br />

50000<br />

25000<br />

0<br />

1 10 100 1000<br />

0<br />

1 10 100 1000<br />

Veratridine Concentration ( M)<br />

Tetrodotoxin Concentration (nM)<br />

EC 50 = 32 M<br />

IC 50 = 38 nM<br />

26


Summary of Data<br />

Cell Line<br />

SH-SY-5Y<br />

ND7/23<br />

Kelly<br />

BE(2)C<br />

EC 50 Veratridine<br />

24µM; n=6<br />

29µM; n=6<br />

31µM; n=6<br />

24µM; n=6<br />

IC 50 Tetrodotoxin<br />

30nM; n=3<br />

11nM; n=3<br />

23nM; n=3<br />

34nM; n=3<br />

27


Assay Optimisation<br />

Dye loading at 25 o C for 30min is better<br />

than at 37 o C for 60min<br />

Assay carried out at 25 o C<br />

Dye concentration can be reduced by<br />

5 fold<br />

28


Summary<br />

Tetrodotoxin sensitive voltage gated<br />

sodium channels have been assayed in<br />

neuroblastoma cell lines using the<br />

<strong>Molecular</strong> <strong>Devices</strong> Membrane Potential<br />

Assay Kit<br />

29


Conclusions<br />

FLEXstation has been successfully used<br />

to…<br />

Develop assays that analyze voltage-gated<br />

calcium and sodium channels expressed in<br />

neuroblastoma cell lines<br />

Carry-out a medium throughput screen on<br />

voltage-gated calcium channels<br />

30


Acknowledgements<br />

<strong>Molecular</strong> Pharmacology Group<br />

Dave Thomas<br />

Stuart Ward<br />

Kathryn Elsegood<br />

Zoe Gladwell<br />

31

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!